Health
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 | FDA – FDA.gov
FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
For Immediate Release:
June 04, 2021
Today, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity. This under-the-skin injection is the first approved drug for chronic weight management in adults with…
-
General12 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News21 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General12 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News16 hours agoBrisbane rising on global rankings, but still behind southern capitals